Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Market Cap	96.72M +95.7%
Revenue (ttm)	34.70M +22.9%
Net Income	7.22M +102.1%
EPS	0.20 +102.1%
Shares Out	36.00M
PE Ratio	13.40
Forward PE	n/a
Dividend	0.05 (1.98%)
Ex-Dividend Date	Apr 16, 2026

Volume	166
Open	3.700
Previous Close	n/a
Day's Range	n/a
52-Week Range	1.900 - 4.000
Beta	0.46
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 15, 2026

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd., together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. The company offers over the counter, prescription pharmaceutical, and nutritional supplements products in various dosage forms, including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, and ointments, as well as ear and nose drops and solutions. It also provides medical devices...

• Industry: Pharmaceutical Preparations
• Founded: 1969
• Employees: 595
• Stock Exchange: Palestine Stock Exchange
• Ticker Symbol: JPH

Financial Performance

In 2025, Jerusalem Pharmaceuticals's revenue was $48.95 million, an increase of 22.91% compared to the previous year's $39.82 million. Earnings were $10.18 million, an increase of 102.13%.

Financial numbers in USD